$40M sweet spot round size
Most of their 6 investments are in rounds between $30M and $45M
2018
Outpace Bio raised $30M on March 31, 2021
Investors: ARTIS Ventures, Washington Research Foundation, Abstract Ventures, Civilization Ventures, Playground Global, Sahsen Ventures, LLC and Lyell Immunopharma
Undisclosed raised $70M on September 30, 2020
Investors: Lilly Asia Ventures, Octagon Capital, Lifeforce Capital, 8VC, JDRF T1D Fund, ARCH Venture Partners and Lyell Immunopharma
Sonoma Biotherapeutics raised $30M on September 30, 2020
Investors: Octagon Capital, Lilly Asia Ventures, JDRF T1D Fund, Lifeforce Capital, 8VC, ARCH Venture Partners and Lyell Immunopharma
CERo Therapeutics, Inc. raised $40M on March 18, 2020
Investors: Sequoia Capital China, ARCH Venture Partners and Lyell Immunopharma
Eureka Therapeutics, Inc raised $45M on March 17, 2020
Investors: Lyell Immunopharma
Sonoma Biotherapeutics raised $40M on February 6, 2020
Investors: 8VC, Milky Way Ventures, ARCH Venture Partners and Lyell Immunopharma